A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

Phase 1 Completed 37 enrolled Celltrion

Non-randomizedCrossoverOpen-labelTreatment

Summary

This is a two-arm, open-label, single-sequence, multiple-dose, cross-over phase 1 study to evaluate the interaction between two investigational drugs by comparing and analyzing the pharmacokinetic interaction and safety of CTL0801 and CTL0802 at steady state when administered alone or in combination with repeated oral doses in healthy adult volunteers.

Timeline

Start: 2021-07-23
Primary completion: 2021-08-29
Completion: 2021-09-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CTL0801	Unknown	—	Oral
Subject	CTL0802	Unknown	—	Oral

Indications

No indication recorded.